Grassley, Kohl push Medicare on Sunshine Act

MassDevice.com covers the Sunshine Act

A bipartisan duo in the U.S. Senate is again pushing the Centers for Medicare & Medicaid Services to finalize the Sunshine Act, which requires medical device and pharmaceutical companies to file detailed reports on payments and gifts to physicians and other health care providers.

In an April 4 letter to CMS chief Marilyn Tavenner, Sens. Chuck Grassley (R-Iowa) and Herb Kohl (D-Wis.) said they’re disappointed that CMS blew the October 2011 deadline for implementing the Sunshine Act.

"We request that the final rule on implementation be released no later than June of this year so that partial data collection for 2012 can commence," the senators wrote (PDF). "We also strongly urge CMS to work closely with stakeholders to finalize these rules to that they comprise a feasible approach to providing the valuable data that patients deserve."

A call for public comments closed in February and the rulemaking period is in progress, meaning the agency retreats behind closed doors while it promulgates the final rules into law. That in turn will leave companies with 90 days to implement their reporting procedures, meaning they could be required to begin reporting data to CMS during the 4th quarter.

That’s a tight timeline given the scope of the tax, Michaeline Daboul, president & CEO of compliance software provider MMIS, told MassDevice.com. Companies must first identify "covered recipients" – that is, the health care providers on their rosters that they’re required to report on. Then companies must aggregate every payment and transfer of value the law requires, link them to the appropriate recipient and feed the data into a system that will generate the necessary federal and state reports, Daboul said.

“They’ve got to put something in place that can actually correctly identify who they’re transferring that value to," she explained. "The bigger problem that people aren’t even thinking about right now is what happens when that information gets published in the public domain. Do you proactively show data before reporting?"

CMS strongly recommends that companies notify covered recipients that they’re about to be mentioned in a report, rather than waiting to resolve the inevitable mistakes and disputes until after publication. The onus is on industry to prove and verify each reported transaction, Daboul noted.

"Industry has no procedures or tools to do this. Companies large and small are all struggling, because they have no idea how they’re going to deal with this," she said. "Your customer is your bread and butter, so you should make sure your customers are happy and they absolutely know you’ve got their backs. It’s much easier for someone who knows proactively that their name is going to be up in lights. Every detail is going to be out there for the public to see, so it behooves industry to take a proactive approach to protect that customer relationship."

Unlike portions of the Affordable Care Act like the medical device tax that have met with stiff opposition from the private sector, the transparency measure has the support of industry. Voluminous responses from individual companies and AdvaMed during the comment period indicate their acceptance of the Sunshine Act, Daboul noted.

"No one is stating that this should be repealed. They’re accepting this, but they’re saying, ‘We think the interpretation of certain payments should be changed. The only other thing people are saying is, ‘We need more time.’"

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply